DOI QR코드

DOI QR Code

Predicting Environmental Concentrations of Selected Pharmaceuticals Using the PhATETM Model in Keum-River, Korea

PhATETM 모형을 적용한 금강수계 중 의약물질 농도 추정

  • Lim, Deuck-Soon (Department of Environmental Health Sciences, Soonchunhyang University) ;
  • Park, Jeong-Im (Department of Environmental Health Sciences, Soonchunhyang University)
  • 임득순 (순천향대학교 환경보건학과) ;
  • 박정임 (순천향대학교 환경보건학과)
  • Published : 2009.02.28

Abstract

In recent years, pharmaceuticals in the aquatic environment have become a matter of increasing public concern. Environmental risk assessment (ERA), including an exposure assessment, is considered the best scientifically based approach for evaluating the potential effects of pharmaceuticals on ecosystems. Computerized exposure models constitute an important tool in predicting environmental exposures of pharmaceuticals. This paper presents the applicability of an exposure model by comparing measured data of selected pharmaceuticals with predicted environmental concentrations from an exposure model. $PhATE^{TM}$ (Pharmaceutical Assessment and Transport Evaluation) model developed by the Pharmaceutical Research and Manufacturers of America (PhRMA) was adapted to run simulations for the Keum River. A set of 7 pharmaceuticals of high production in Korea was modeled. The PECs generated by the $PhATE^{TM}$ model that were then compared to the measured concentrations. The $PhATE^{TM}$ model predicted concentrations for 7 pharmaceuticals including acetaminophen, acetylsalicylic acid, erythromycin, ibuprofen, lincomycin, mefenamic acid, and naproxen were in good agreement with actual measured concentrations, which demonstrated the utility of $PhATE^{TM}$ as a predictive tool. In conclusion, $PhATE^{TM}$, although it does not intend to accurately represent reality, could be utilized for rapid predictions of the environmental concentrations of pharmaceuticals.

Keywords

References

  1. Daughton, C. G., Jones-Lepp, T. (Eds.) : Phannaceuticals and Personal Care Products in the Environment: Scientifk and Regulatory Issues. Symposium Series 791, American Chemical Society, Washington DC, 2001
  2. Ternes, T. A. : Occurrence of drugs in German sewagetreatment plants and rivers. Water Research, 32(11), 3245-3260, 1998 https://doi.org/10.1016/S0043-1354(98)00099-2
  3. Kim. M. H., Park, J. 1., Kim, Y. H. and Choi, K. H. : Prioritizing human use antibiotics for Environmental health management and estimating their environmental concentrations in Korean waterway. Korean Journal of Environmental Health, 32(5), 462-468, 2006
  4. Koo, S. H., Cho, H. W. and Myung, S. W. : Analysis of pharmaceuticals and personal care products ($PPCP_{s}$) from the environmental samples by LC/ESI-MS/MS. Korean Society for Environmental Analysis, 10(4), 237-247, 2007
  5. Carballa, M., Omil, F., Lema, J. M., Llompart, M.,Garcia-Jares, c., Rodriguez, I., Gomez, M. and Ternes, T. : Behavior of phamlaceuticals, cosmetics and hormones in a sewage treatment plant. Water Research, 38(12), 2918-2926, 2004 https://doi.org/10.1016/j.watres.2004.03.029
  6. Park, J. I. : Environmental Risk Assessment of Pharmaceuticals : Model Application for Estimating Pharmaceutical Exposures in the Han River Basin, Korea Environment Institute, Seoul 2007
  7. Anderson, P. D., D'aco, V. J., Shanaha, P., Ahapra, S.C., Buzby, M. E., Cunningham, V. L, Duplessie, B.M., Hayes, E. P., Marstrocco, F. J., Parke, N. J.,Rader, J. c., Samuelian, J. H. and Schwab, B. W. :Screening Analysis of human Pharmaceutical Compounds in U.S. Surface Waters. Environmental Science and Technology, 38(3), 838-849, 2004 https://doi.org/10.1021/es034430b
  8. Schowanek, D. and Webb, S. : Exposure simulation for pharmaceuticals in European surface waters with GREAT-ER. Toxicology Letters, 131(1-2), 39-50, 2004 https://doi.org/10.1016/S0378-4274(02)00064-4
  9. Water Management Infonnation System, http//www. wamis.go.kr
  10. Ministry of Environment: Statics of Sewerage, 2008
  11. Park, J. I : An approach for Developing aquatics Environmental Risk Assessment Framework for Pharmaceuticals in Korea, Korea Environment Institute, Seoul 2006
  12. Korea National Statistical Office, http//www.nso.go.kr
  13. Ministry of Environment, Korea Land Corporation:Study for calculating the unit load of wastewater generation from housing areas and for estimating its reatment cost, 2001
  14. US EPA: Guidance for the Industry: Environmental Assessment of Human Drug and Biologics Applications,1998
  15. National Institute of Environmental Research: Development of analytical methods for phannaceuticals and personal care products and their occurrences in the Environment I, 2006
  16. National Institute of Environmental Research: Development of analytical methods for phannaceuticals and personal care products and their occurrences in the Environment II, 2007
  17. Jones, O. A. H., Voulvoulis, N. and Lester, J. N. : Aquatic environmental assessment of the top 25 English pres(.Tiption pharmaceuticals. Water Research,36(20), 5013-5022, 2002 https://doi.org/10.1016/S0043-1354(02)00227-0
  18. Ministry of Construction & Transportation : Master Planning Reports on River Improvement of Geum River, 2002
  19. Ministry of Construction & Transportation: Annual Hydrological Report, 2002
  20. http://pre-pg.blogspot.com/2008/01/acetaminophentylenoi. html
  21. http://dmd.aspetjournals.org/cgilcontent/fuI1l26/4/332
  22. http://www.rxlist.com/cgilgeneric/mefenamic_cp.htrn
  23. http://www.freepatentsonline.com/4601895.htmI
  24. http://doi.wiley.com/10.1002/jps.2600691105
  25. http://home.intekom.comlpharmladcockla-eryth.htrnl
  26. http://www.emea.europa.eulpdfs/vet/mris/049798en.pdf
  27. G\acute{o}mez, M. J., Mart\acute{i}nez Bueno, M. J., Lacorte, S.,Fernandez-Alba, A. R. and Agiiera, A. : Pilot survey monitoring phannaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 66(6), 993-1002, 2007 https://doi.org/10.1016/j.chemosphere.2006.07.051
  28. US EPA: EPI Suite ver. 2.0, http://epa.gov/opptintr/exposure/pubs/episuite.htm
  29. EMEA : Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use, 2006
  30. US EPA, http://www.epa.gov/oppt/exposurelpubslepisuite.htm